Nicole A. Traphagen, PhD

[Ph]inishe[D]! What a day, so grateful for everyone who came to support me and celebrate! @MCBDartmouth @CancerDartmouth @MSBDartmouth @dartmouth

Ludwig @harvardmed's @NicoleTraphagen discusses the research she presented at #AACR24 in a poster titled, "Defining androgen receptor function and the effects of PARP inhibition in BRCA1/2-deficient vs. proficient prostate cancer."

New paper in @CCR_AACR from the @TMillerLab features a host of MCB students: lead author MCB alum @NicoleTraphagen along with current MCBers @Steven_S_Tau, Alyssa Roberts, Abigail Goen, @AnnekaLJohnson, and Emily-Claire Duffy! Cool therapeutic potential in combining treatments:

Estrogen therapy induces receptor-dependent DNA damage enhanced by PARP inhibition in ER+ breast cancer biorxiv.org/cgi/content/sh… #bioRxiv

Congratulations to Drs. Sara Tolaney, Myles Brown, Geoff Shapiro, Alan D'Andrea and several other @DanaFarber colleagues who were included in @Clarivate's list of the world's most highly-cited researchers! 👏👏👏@stolaney1 @GShapiroMDPhD dana-farber.org/newsroom/news-…

Turns out science is best discussed on a beach. Thanks for a great week in Malta @EMBO #EMBOnuclearReceptors!

@mwilli323 @theNCI @CUAnschutz Congratulations!

Astonished that I received a K99/R00 from @theNCI to continue my postdoc training @CUAnschutz, after which I’ll have support to start my own research group dedicated to improving immunotherapy treatments for breast cancer patients with liver metastasis.

@becky_reese17 Congratulations Dr. Reese!

They say a PhD is a marathon not a sprint, but in reality it’s usually both at once. So grateful to have had the best advisor and labmates in @DartmouthLab to help get me to the finish line! @dartmouth @DartmouthCancer @MCBDartmouth

graduate.dartmouth.edu/news/2022/05/2… @KateNautiyal and @DartmouthLab are the 2022 faculty mentoring award recipients!#dartGRAD #mentoring

@becky_reese17 Congratulations!!

Really hope we're not giving up on oral SERDs with the giredestrant news. Seems like the 'failed' trials result from poor trial design and not lack of efficacy- why focus on lack of superior PFS when the appeal of these drugs is improved quality of life?

One week from today I’ll be presenting my thesis work!

@jmdelgado_ Congratulations!

Couldn't have done it without the immense support from my peers, colleagues, and most importantly my mentor Chris!

New city, new job, new photo

The perfect mug for my last official day as a student!

@laurynrwerner @HaganlabKUMC Congratulations!

Arguably one of the best emails I’ve gotten as a MD/PhD student. Time to pop some bottles @HaganlabKUMC 🥳 #F30 #doubledocs

@HaganlabKUMC @MCBDartmouth @CancerDartmouth @MsbDartmouth @dartmouth Thank you!

@NicoleTraphagen @MCBDartmouth @CancerDartmouth @MsbDartmouth @dartmouth Congrats!!

[Ph]inishe[D]! What a day, so grateful for everyone who came to support me and celebrate! @MCBDartmouth @CancerDartmouth @MSBDartmouth @dartmouth

@marnieeh @MCBDartmouth @CancerDartmouth @MsbDartmouth @dartmouth Thank you!

@eearah @MCBDartmouth @CancerDartmouth @MsbDartmouth @dartmouth Thanks Iara!

@itsnot_pink @MCBDartmouth @CancerDartmouth @MsbDartmouth @dartmouth @GRASPtweets Thank you! Looking forward to it too!

@NicoleTraphagen @MCBDartmouth @CancerDartmouth @MsbDartmouth @dartmouth Congratulations!! Looking forward to more @GRASPtweets discussions!